NPPA fixes price of 84 formulations, revises 1 Ruchika Sharma13 May 2022 9:30 AM GMTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 84 formulations and has...
NPPA fixes retail prices of Linagliptin, Sitagliptin FDCs, Details Ruchika Sharma11 May 2022 12:30 PM GMTNew Delhi: Through a recent notice, National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of the fixed dose combinations (FDCs)...
Ahead of Sitagliptin going off-Patent, NPPA moves to fix retail price of its FDC Meghna Singhania Meghna A Singhania15 April 2022 11:52 AM GMTNew Delhi: With the popular antidiabetic drug Sitagliptin soon expected to go off-patent, the apex drug price regulator, National Pharmaceutical...
Macleod Pharma gets CDSCO panel conditional nod to study FDC Sitagliptin, Metformin, Glimepiride Susmita Roy28 March 2022 1:32 PM GMTNew Delhi: Pharmaceutical major, Macleods Pharmaceuticals has got the go-head from the Subject Expert Committee (SEC) of the Central Drug Standard...
Drug makers to include DPP4 inhibitors induced Arthralgia in package insert, says CDSCO panel Medical Dialogues Team15 Jan 2022 12:05 PM GMTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has recommended that CDSCO may...
Alkem gets CDSCO panel okay to manufacture, market Metformin, Sitagliptin FDC Medical Dialogues Team12 Nov 2021 12:48 PM GMTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has granted permission to...
Unichem Labs diabetes drug Sitagliptin gets USFDA approval Ruchika Sharma11 July 2021 6:30 AM GMTSitagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Sun Pharma gets CDSCO panel ok for BE study of Sitagliptin, Metformin, Glimepiride FDC Medical Dialogues Team24 Jun 2021 11:22 AM GMTNew Delhi: Pharmaceutical major, Sun Pharmaceuticals has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Patent Infringement: MSD sues firm in Delhi HC over diabetes drug Sitagliptin Medical Dialogues Team20 Jun 2021 6:00 AM GMTNew Delhi: In a major victory for Merck Sharp and Dohme (MSD) Corp, the Delhi High Court has restrained Solitaire Pharmacia Private from infringing...
Delhi HC Restrains Firm From Infringing on MSD Diabetes Drug Sitagliptin Medical Dialogues Team8 Jun 2021 3:06 PM GMTNew Delhi: In a major relief to Merck Sharp & Dohme Corp, the Delhi High Court has barred YMS Laboratories Private Limited from infringing on...
Himachal drugmaker agrees to destroy infringed stock of Merck Diabetes Drug Sitagliptin Medical Dialogues Team7 April 2021 1:12 PM GMTNew Delhi: In a relief to Merck, Hariom Pharmachem has agreed to destroy the stock of infringed products of Merck's popular diabetes drug Sitagliptin,...
Citing voglibose, sitagliptin incompatibility, CDSCO panel rejects Hetero Labs proposal for antidiabetic FDC drug Medical Dialogues Team13 March 2021 1:20 PM GMTNew Delhi: In a setback to Hetero Labs, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO)...
